Product Information
HYDROXYZINE PAM 50 MG CAP is a generic product labeled by Sandoz Inc., priced at $0.0820 per EA under NDC 00185067601. Its NADAC has been published 256 times since Nov 10, 2021.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Sandoz Inc.NDC
00185067601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA086183FDA Approved
Before 1982
TE Code
AB
On Market Since
12/14/1981
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 50 MG CAP has been published 256 times since Nov 10, 2021, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0820 per EA |
|---|---|
| All-time high | $0.1088 (Jul 12, 2023) |
| All-time low | $0.0683 (Apr 17, 2024) |
| 52-week high | $0.0851 |
| 52-week low | $0.0796 |
| Median price | $0.0849 |
| Average price | $0.0879 |
| Largest weekly change | +14.9% (Jun 21, 2023) |
| Weeks tracked | 256 |
| Tracking since | Nov 10, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydroxyzine Pamoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 50 MG CAP, manufactured by Sandoz Inc., is $0.0820 per EA (NDC 00185067601), effective Sep 30, 2026.
How has the price of HYDROXYZINE PAM 50 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 50 MG CAP has declined 4.5%. It has been tracked across 256 weekly CMS publications since Nov 10, 2021.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 50 MG CAP?
Since Nov 10, 2021, the NADAC for HYDROXYZINE PAM 50 MG CAP has ranged from a low of $0.0683 (Apr 17, 2024) to a high of $0.1088 (Jul 12, 2023), with a median of $0.0849 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 50 MG CAP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYZINE PAM 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 50 MG CAP?
HYDROXYZINE PAM 50 MG CAP (NDC 00185067601) is labeled by Sandoz Inc., and CMS classifies it as a generic product.